Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Mitochondrial genes delivered in vivo confer protection against renal I/R injury

May 5, 2014

Allena Pharmaceuticals reports phase I data for ALLN-177

May 2, 2014

PAR-1 antagonist F-16357 dose-dependently inhibits bladder contraction

April 28, 2014

New bicyclic derivatives synthesized by Roche

April 25, 2014

Torii Pharmaceutical set to launch Riona in Japan for the treatment of hyperphosphatemia

April 22, 2014

OxThera receives financing to continue key clinical programs

April 17, 2014

Prevention of PGE2-induced bladder overactivity by TRPM8 blocker DFL-23448

April 17, 2014

French team presents novel V2 receptor antagonist peptides

April 10, 2014

EMA validates Keryx Biopharmaceuticals' MAA for Zerenex

April 3, 2014

AM-Pharma reports phase I data for recombinant human alkaline phosphatase

March 31, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...